- Home
- ANVS vs NIXX Comparison
ANVS vs NIXX Comparison
Compare ANVS & NIXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANVS
- NIXX
- Stock Information
- Founded
- ANVS 2008
- NIXX 2010
- Country
- ANVS United States
- NIXX United States
- Employees
- ANVS N/A
- NIXX N/A
- Industry
- ANVS Biotechnology: Pharmaceutical Preparations
- NIXX
- Sector
- ANVS Health Care
- NIXX
- Exchange
- ANVS Nasdaq
- NIXX NYSE
- Market Cap
- ANVS 44.6M
- NIXX 49.9M
- IPO Year
- ANVS 2020
- NIXX N/A
- Fundamental
- Price
- ANVS $2.75
- NIXX $2.23
- Analyst Decision
- ANVS Strong Buy
- NIXX
- Analyst Count
- ANVS 4
- NIXX 0
- Target Price
- ANVS $18.00
- NIXX N/A
- AVG Volume (30 Days)
- ANVS 437.3K
- NIXX 373.8K
- Earning Date
- ANVS 08-14-2025
- NIXX 08-13-2025
- Dividend Yield
- ANVS N/A
- NIXX N/A
- EPS Growth
- ANVS N/A
- NIXX N/A
- EPS
- ANVS N/A
- NIXX N/A
- Revenue
- ANVS N/A
- NIXX $1,786,387.00
- Revenue This Year
- ANVS N/A
- NIXX N/A
- Revenue Next Year
- ANVS N/A
- NIXX N/A
- P/E Ratio
- ANVS N/A
- NIXX N/A
- Revenue Growth
- ANVS N/A
- NIXX 54.16
- 52 Week Low
- ANVS $1.11
- NIXX $1.35
- 52 Week High
- ANVS $14.80
- NIXX $8.50
- Technical
- Relative Strength Index (RSI)
- ANVS 57.81
- NIXX N/A
- Support Level
- ANVS $2.24
- NIXX N/A
- Resistance Level
- ANVS $2.97
- NIXX N/A
- Average True Range (ATR)
- ANVS 0.26
- NIXX 0.00
- MACD
- ANVS 0.02
- NIXX 0.00
- Stochastic Oscillator
- ANVS 65.58
- NIXX 0.00
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
About NIXX NIXXY INC
Nixxy Inc is a hiring platform for the network of recruiters. It empowers businesses to recruit specialized talent faster with virtual teams of recruiters and AI job-matching technology.Recently, the Company acquired the license from GoLogiq, Inc. (GoLogiq), to operate its fintech technology (the GOLQ Technology) and sell products derived thereof, including its Createapp, Paylogiq, Gologiq, and Radix AI technology and products.. Its Recruiters On Demand provides businesses of all sizes access to virtual recruiters specialized by vertical industries to source, engage, and hire talent on an as-needed basis.